ahd.com

Oncology

  • MS-DRGs are grouped by "Medical Service" to provide a meaningful way of summarizing utilization data.
  • MS-DRGs are based on FY 2021 regulations.
MS-DRG MS-DRG Description
014 ALLOGENEIC BONE MARROW TRANSPLANT
016 AUTOLOGOUS BONE MARROW TRANSPLANT WITH CC/MCC
017 AUTOLOGOUS BONE MARROW TRANSPLANT WITHOUT CC/MCC
018 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY
054 NERVOUS SYSTEM NEOPLASMS WITH MCC
055 NERVOUS SYSTEM NEOPLASMS WITHOUT MCC
146 EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MCC
147 EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH CC
148 EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITHOUT CC/MCC
180 RESPIRATORY NEOPLASMS WITH MCC
181 RESPIRATORY NEOPLASMS WITH CC
182 RESPIRATORY NEOPLASMS WITHOUT CC/MCC
374 DIGESTIVE MALIGNANCY WITH MCC
375 DIGESTIVE MALIGNANCY WITH CC
376 DIGESTIVE MALIGNANCY WITHOUT CC/MCC
435 MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC
436 MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH CC
437 MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITHOUT CC/MCC
597 MALIGNANT BREAST DISORDERS WITH MCC
598 MALIGNANT BREAST DISORDERS WITH CC
599 MALIGNANT BREAST DISORDERS WITHOUT CC/MCC
686 KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC
687 KIDNEY AND URINARY TRACT NEOPLASMS WITH CC
688 KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC
722 MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC
723 MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC
724 MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC
754 MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC
755 MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC
756 MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC
834 ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH MCC
835 ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH CC
836 ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITHOUT CC/MCC
837 CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC
838 CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT
839 CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC
840 LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC
841 LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC
842 LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC
843 OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC
844 OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC
845 OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC
846 CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC
847 CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC
848 CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC
849 RADIOTHERAPY